Burning Rock Biotech (BNR) Short-term Investments (2019 - 2025)

Burning Rock Biotech's Short-term Investments history runs 7 years deep, the most recent figure standing at $380116.1 for Q4 2025.

• In Q4 2025, Short-term Investments rose 18.05% year-over-year to $380116.1; the TTM figure through Dec 2025 stood at $380116.1 (up 18.05% YoY), while the FY2025 annual figure was $386000.0, up 21.77% from the prior year.
• Short-term Investments was $380116.1 for Q4 2025 at Burning Rock Biotech, down from $419000.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $4.7 million in Q2 2021 to a low of $8000.0 in Q1 2024.
• Historically, Short-term Investments has averaged $1.2 million across 5 years, with a median of $399558.0 in 2025.
• The sharpest annual moves came in 2021 and 2024: Short-term Investments soared 12600.0% in 2021, then slumped 99.43% in 2024.
• A 5-year view of Short-term Investments shows it stood at $1.2 million in 2021, then surged by 128.54% to $2.8 million in 2022, then plunged by 99.4% to $16666.5 in 2023, then jumped by 1832.06% to $322006.0 in 2024, then grew by 18.05% to $380116.1 in 2025.
• The last three Short-term Investments figures came in at $380116.1 (Q4 2025), $419000.0 (Q3 2025), and $321000.0 (Q2 2025), per Business Quant data.